Radioimmunotherapy of cancer: clinical studies and limiting factors

Cancer Treatment Reviews

Volumn 14, Issue 2, 1987, Pages 87-106

  Dykes, P W ^a   Bradwell, A R ^a   Chapman, C E ^a   Vaughan, A T M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

CANCER THERAPY; HUMAN; RADIOIMMUNOTHERAPY; REVIEW;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; HUMAN; IMMUNOTHERAPY; MODELS, BIOLOGICAL; NEOPLASMS; RADIOISOTOPES; SUPPORT, NON-U.S. GOV'T;

EID: 0023521040     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/0305-7372(87)90042-9     Document Type: Article

References (71)

1. The localisation of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours
2. Imaging of bone tumours using a monoclonal antibody raised against human osteosarcoma
3. Tumour location using F(ab')2u from a monoclonal IgM antibody: Pharmacokinetics
4. Limiting factors in the localisation of tumours with radiolabelled antibodies
5. Radiolabelled fragments of monoclonal antibodies against carcinoembryonic antigen for localisation of human colon carcinoma grafted into nude mice
6. Imaging with 1–131 labelled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: Efficacy of whole immunoglobulin and its F(ab')2 fragments
7. Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments
8. Immunoscintigraphy of colon carcinoma
9. Antibody-guided radiation therapy via the CSF for malignant meningitis
10. Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukaemia
11. Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen
12. The relationship of biological effect to dose-time fractionation factors in radiotherapy
13. Antibody guided radiolocalisation of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphatase
14. Limitations of radiolabelled monoclonal antibodies for localisation of human neoplasms
15. Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen
16. Isotopic immunoglobulin in an integrated multimodal treatment program for a primary liver cancer: a case report
17. Phase-I-II study of isotopic immunoglobulin therapy for primary liver cancer
18. Improved tumour localisation using indium-111 labelled antibodies
19. Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody
20. Localisation of 131-I-labelled antibodies in human renal cell carcinomas and in a mouse hepatoma and correlation with tumour detection by photoscanning
21. Use of radiolabelled antibodies to carcinoembryonic antigen for the detection and localisation of diverse cancers by external photoscanning
22. Clinical radioimmunodetection of cancer with radioactive antibodies to human chorionic gonadotrophin
23. Clinical studies on the radioimmunodetection of tumours containing alpha-fetoprotein
24. Pilot trial of murine monoclonal antibodies in patients with advanced melanoma
25. Use of specific antibody for rapid clearance of circulating blood background from radiolabelled tumour imaging proteins
26. The preparation of 131-I-labelled human growth hormone of high specific radioactivity
27. Antibody-guided irradiation of malignant lesions: Three cases illustrating a new method of treatment
28. Monoclonal antibodies to carcinoembryonic antigen: Ionic strength as a factor in the selection of antibodies for immunoscintigraphy
29. Traitement d'un cas de sarcome par la serotherapie
30. De la serotherapie dans le traitement du cancer
31. DTPA-coupled antibodies labelled with yttrium-90
32. Radioactive labelling of antibody: A simple and efficient method
33. The preparation and labelling of DTDA-coupled albumin
34. Dosimetric aspects of radiolabeled antibodies for tumor therapy.
35. Radioimmunodetection of cancer using radiolabelled antibodies to alphafetoprotein
36. Characteristics of first and second antibodies for tumour imaging
37. Therapeutic application of radiolabelled monoclonal antibody UJ13A in children with disseminated neuroblastoma
38. Some Radiobiological Considerations in Radiotherapy
39. Imaging of melanoma with I-131-labelled monoclonal antibodies
40. Dosimetry of I-131-labelled antiferritin in hepatoma: Specific activities in the tumour and liver
41. Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease
42. Treatment of advanced primary hepatocellulr carcinoma by 131-anti-AFP
43. Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy
44. Use and limitations of radiolabelled anti-CEA antibodies and their fragments for photoscanning detection of human colorectal carcinomas
45. Tumour localistation in patients by radiolabelled monoclonal antibodies against colon carcinoma
46. Tumour localization of radiolabelled antibodies against carcinoembryonic antigen in patients with carcinoma
47. Time course localisation of immunoglobulin M monoclonal antibody and its fragments in leukemic tumour-bearing mice
48. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer
49. A clinical trial of anti-idiotype therapy for B cell malignancy
50. Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma
51. Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen
52. Biological significance of carbohydrate chains on monoclonal antibodies
53. Phase I-II study of radiolabelled antibody integrated into the treatment of primary hepatic malignancies
54. 90-Yttrium antiferritin-a new therapeutic radiolabeled antibody
55. Iodine-131 antiferritin, a new treatment modality in hepatoma: a radiation therapy oncology group study
56. Intracavitary bleomycin in the management of malignant effusions: A multicentre study
57. Antibody-guided irradiation of malignant pleural and pericardial effusions
58. The chracteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients
59. The development and use of radiolabelled anti-tumor antibodies
60. The in vivo localisation of anti-Wagner-Osteogenic-sarcoma antibodies
61. The zone of localisation of antibodies. III. The specific localisation of antibodies to rat kidney
62. The use of paired labelling in the determination of tumourlocalising antibodies
63. Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-III
64. Phase II trial of a murine monoclonal antibody cytoxic for gastrointestinal adenocarcinoma
65. Estimates of specific absorbed fractions for photon sources uniformly distributed in various organs of a heterogenous phantom
66. I-131-Labeled antibodies to human fibrinogen. Diagnostic studies and therapeutic trials
67. Immunoscintigraphy for detection of lymph node metastases from breast cancer
68. Yttrium-90 labelled antibodies: Biological distribution and post-injection manipulation of the yttrium ion
69. The production and biological distribution of yttrium-90 labelled antibodies
70. Limitations to tumour killing using radiolabelled antibodies